Bernards R - Search Results

1

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K, Linn SC, Gonzalez-Angulo AM, Stemke-Hale K, Hauptmann M, Beijersbergen RL, Mills GB, van de Vijver MJ, Bernards R. Berns K, et al. Among authors: bernards r. Cancer Cell. 2007 Oct;12(4):395-402. doi: 10.1016/j.ccr.2007.08.030. Cancer Cell. 2007. PMID: 17936563 Free article. Clinical Trial.

2

Molecular and functional characterisation of E2F-5, a new member of the E2F family.

Buck V, Allen KE, Sørensen T, Bybee A, Hijmans EM, Voorhoeve PM, Bernards R, La Thangue NB. Buck V, et al. Among authors: bernards r. Oncogene. 1995 Jul 6;11(1):31-8. Oncogene. 1995. PMID: 7542760

3

Zhu L, Enders G, Lees JA, Beijersbergen RL, Bernards R, Harlow E. Zhu L, et al. Among authors: bernards r. EMBO J. 1995 May 1;14(9):1904-13. doi: 10.1002/j.1460-2075.1995.tb07182.x. EMBO J. 1995. PMID: 7743997 Free PMC article.

4

E2F-5, a new E2F family member that interacts with p130 in vivo.

Hijmans EM, Voorhoeve PM, Beijersbergen RL, van 't Veer LJ, Bernards R. Hijmans EM, et al. Among authors: bernards r. Mol Cell Biol. 1995 Jun;15(6):3082-9. doi: 10.1128/MCB.15.6.3082. Mol Cell Biol. 1995. PMID: 7760804 Free PMC article.

5

Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.

Beijersbergen RL, Carlée L, Kerkhoven RM, Bernards R. Beijersbergen RL, et al. Among authors: bernards r. Genes Dev. 1995 Jun 1;9(11):1340-53. doi: 10.1101/gad.9.11.1340. Genes Dev. 1995. PMID: 7797074 Free article.

6

E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.

Beijersbergen RL, Kerkhoven RM, Zhu L, Carlée L, Voorhoeve PM, Bernards R. Beijersbergen RL, et al. Among authors: bernards r. Genes Dev. 1994 Nov 15;8(22):2680-90. doi: 10.1101/gad.8.22.2680. Genes Dev. 1994. PMID: 7958925 Free article.

7

Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.

Beijersbergen RL, Hijmans EM, Zhu L, Bernards R. Beijersbergen RL, et al. Among authors: bernards r. EMBO J. 1994 Sep 1;13(17):4080-6. doi: 10.1002/j.1460-2075.1994.tb06725.x. EMBO J. 1994. PMID: 8076603 Free PMC article.

8

N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.

van 't Veer LJ, Beijersbergen RL, Bernards R. van 't Veer LJ, et al. Among authors: bernards r. EMBO J. 1993 Jan;12(1):195-200. doi: 10.1002/j.1460-2075.1993.tb05645.x. EMBO J. 1993. PMID: 8428579 Free PMC article.

9

Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.

Smith-Sørensen B, Hijmans EM, Beijersbergen RL, Bernards R. Smith-Sørensen B, et al. Among authors: bernards r. J Biol Chem. 1996 Mar 8;271(10):5513-8. doi: 10.1074/jbc.271.10.5513. J Biol Chem. 1996. PMID: 8621409 Free article.

10

Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins.

Beijersbergen RL, Bernards R. Beijersbergen RL, et al. Among authors: bernards r. Biochim Biophys Acta. 1996 Jun 7;1287(2-3):103-20. doi: 10.1016/0304-419x(96)00002-9. Biochim Biophys Acta. 1996. PMID: 8672526 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

331 results

Search Page